• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

High molecular hyaluronic acid regulates the differentiation of injured tendon-derived progenitor cells

Research Project

Project/Area Number 18K16618
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 56020:Orthopedics-related
Research InstitutionNagoya University

Principal Investigator

Asai Shuji  名古屋大学, 医学部附属病院, 講師 (00770893)

Project Period (FY) 2018-04-01 – 2023-03-31
Project Status Completed (Fiscal Year 2022)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Keywords腱 / 変性 / ヒアルロン酸 / 間葉系幹細胞 / MAPK
Outline of Final Research Achievements

In this study, using a mouse Achilles tendon injury model and progenitor-like cells isolated from the injured tendon, we found the followings: (1) high molecular weight hyaluronic acid inhibits chondrogenic differentiation of injured tendon-derived progenitor-like cells and promotes tenogenic differentiation, (2) 4-Methylumbelliferone (4-MU), an inhibitor of hyaluronan synthesis, promotes chondrogenic differentiation of injured tendon-derived progenitor-like cells, 3) high molecular weight hyaluronic acid inhibits heterotopic mineralization in a mouse Achilles tendon injury model, and 4) 4-MU promotes heterotopic mineralization. These results suggest that high molecular weight hyaluronic acid may inhibit degeneration and promote repair of injured tendons. Further studies are needed to elucidate the molecular mechanism.

Academic Significance and Societal Importance of the Research Achievements

腱損傷部の修復を促進するために,骨髄や脂肪由来の間葉系幹細胞に成長因子を投与することにより腱分化を誘導し,それらの細胞をscaffoldとともに損傷部位に移植する研究が行われている.しかし,いずれの研究も動物実験段階であり,完全な腱組織の獲得には至っていない.また,臨床応用するためには,ドナー細胞を採取する侵襲が患者に加わることが問題のひとつである.本研究で用いた方法により,腱損傷部に自然誘導される幹細胞の腱分化を促進できる可能性があり,ドナー細胞を採取する侵襲を避けることができる.また,ヒアルロン酸は既承認薬であり安全性が担保されており,本研究で得られた成果は臨床に応用しやすいと考える.

Report

(6 results)
  • 2022 Annual Research Report   Final Research Report ( PDF )
  • 2021 Research-status Report
  • 2020 Research-status Report
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (1 results)

All 2022

All Presentation (1 results)

  • [Presentation] ヒアルロン酸はTSPCの軟骨分化を抑制し腱修復を促進する2022

    • Author(s)
      羽賀貴博,浅井秀司,石塚真哉,大羽宏樹,坂口健史,水野隆文,川島至,栗山香菜恵,福井順,藤井整,今釜史郎
    • Organizer
      第37回 日本整形外科学会基礎学術集会
    • Related Report
      2022 Annual Research Report

URL: 

Published: 2018-04-23   Modified: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi